1. Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, Koziel DE, Anderson V, Hilligoss D, Choyke P, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology(45): 675-83, 2007. [Full Text/Abstract]
2. Saito S, Heller T, Yoneda M, Takahashi H, Nakajima A, Liang JT Lifestyle-related diseases of the digestive system: a new in vitro model of hepatitis C virion production: application of basic research on hepatitis C virus to clinical medicine. J Pharmacol Sci(105): 138-44, 2007. [Full Text/Abstract]
3. Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, Wakita T, Liang TJ Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol(81): 4405-11, 2007. [Full Text/Abstract]
4. Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology(46): 424-9, 2007. [Full Text/Abstract]
5. Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, Guay-Woodford L, Harris P, Heller T, Ingelfinger J, Kaskel F, Kleta R, Larusso NF, Mohan P, Pazour GJ, Shneider BL, Torres VE, Wilson P, Zak C, Zhou J, Gahl WA Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a First National Institutes of Health/Office of Rare Diseases conference. J Pediatr (149): 159-164, 2006. [Full Text/Abstract]
6. Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. Clin Gastroenterol Hepatol (4): 1048-52, 2006. [Full Text/Abstract]
7. Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Haematologica (91): 1076-83, 2006. [Full Text/Abstract]
8. Garcia-Eulate R, Hussain N, Heller T, Kleiner D, Malech H, Holland S, Choyke PL CT and MRI of hepatic abscess in patients with chronic granulomatous disease. AJR Am J Roentgenol (187): 482-90, 2006. [Full Text/Abstract]
9. O''Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol (4): 387-94, 2006. [Full Text/Abstract]
10. Reshamwala PA, Kleiner DE, Heller T Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology (44): 7-14, 2006. [Full Text/Abstract]
11. Perumalswami P, Kleiner DE, Lutchman G, Heller T, Borg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection. Hepatology (43): 780-7, 2006. [Full Text/Abstract]
12. Heller T, Rehermann B Acute hepatitis C: a multifaceted disease. Semin Liver Dis (25): 7-17, 2005. [Full Text/Abstract]
13. Heller T, Saito S, Auerbach J, Williams T, Moreen TR, Jazwinski A, Cruz B, Jeurkar N, Sapp R, Luo G, Liang TJ An in vitro model of hepatitis C virion production. Proc Natl Acad Sci U S A (102): 2579-83, 2005. [Full Text/Abstract]
14. Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH Pilot study of interferon gamma for chronic hepatitis C. J Hepatol (43): 67-71, 2005. [Full Text/Abstract]
15. Heller T, Seeff LB Viral load as a predictor of progression of chronic hepatitis C? Hepatology (42): 1261-3, 2005. [Full Text/Abstract]
16. Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology (39): 188-96, 2004. [Full Text/Abstract]
17. Rahman F, Heller T, Sobao Y, Mizukoshi E, Nascimbeni M, Alter H, Herrine S, Hoofnagle J, Liang TJ, Rehermann B Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology (40): 87-97, 2004. [Full Text/Abstract]
18. Radaeva S, Jaruga B, Kim WH, Heller T, Liang TJ, Gao B Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C. Biochem J (379): 199-208, 2004. [Full Text/Abstract]
19. Liang TJ, Heller T Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology (127): S62-71, 2004. [Full Text/Abstract]
20. Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology (124): 352-60, 2003. [Full Text/Abstract]
21. Heller T, Hoofnagle JH Denying the wolf access to sheep''s clothing. J Clin Invest (112): 319-21, 2003. [Full Text/Abstract]
22. Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology (38): 66-74, 2003. [Full Text/Abstract]
23. Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T, Patel A, Kohn LD, Liang TJ Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol (76): 9335-44, 2002. [Full Text/Abstract]
24. Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, Liang TJ, Hoofnagle JH Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology (36): 1273-9, 2002. [Full Text/Abstract]
25. Sarkodee-Adoo C, Pittarelli L, Jaffe E, Sorbara L, Raffeld M, Yao X, Haddad R, Heller T Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma (42): 1125-31, 2001. [Full Text/Abstract]
26. Heller T, Drachenberg CB, Orens JB, Fantry GT Primary posttransplant lymphoproliferative disorder of the gallbladder in a lung transplant patient presenting with acute cholecystitis. Transplantation (69): 668-70, 2000. [Full Text/Abstract]
27. Darwin P, Zangara J, Heller T, Haluszka O, Laurin J Unsedated esophagoscopy for the diagnosis of esophageal varices in patients with cirrhosis. Endoscopy (32): 971-3, 2000. [Full Text/Abstract]
28. Heller T, James SP, Drachenberg C, Hernandez C, Darwin PE Treatment of severe esophageal Crohn''s disease with infliximab. Inflamm Bowel Dis (5): 279-82, 1999. [Full Text/Abstract]
29. Heller T, Yin S, Tsarev SA, Purcell RH, Emerson SU False-positive serologic test resulting from a probable yeast infection in a chimpanzee. Clin Diagn Lab Immunol (3): 614-5, 1996. [Full Text/Abstract]
30. Tobi M, Darmon E, Phillips T, Heller T, Rozen P, Nochomovitz L, Steinberg W Increased expression of a putative adenoma-associated antigen in pre-colonoscopic effluent of patients with colorectal cancer. Cancer Lett (51): 21-5, 1990. [Full Text/Abstract]